Rafael López-Rojas

3.2k total citations · 1 hit paper
35 papers, 2.4k citations indexed

About

Rafael López-Rojas is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Rafael López-Rojas has authored 35 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Medicine, 10 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Rafael López-Rojas's work include Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Vibrio bacteria research studies (5 papers). Rafael López-Rojas is often cited by papers focused on Antibiotic Resistance in Bacteria (27 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Vibrio bacteria research studies (5 papers). Rafael López-Rojas collaborates with scholars based in Spain, France and United States. Rafael López-Rojas's co-authors include Jerónimo Pachón, Roshan Padmanabhan, Marie Kempf, Jean‐Marc Rolain, Seydina M. Diene, Luce Landraud, Sushim K. Gupta, Michael J. McConnell, Juan Domínguez-Herrera and Fernando Docobo-Pérez and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Rafael López-Rojas

34 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes

2013 1.0k citations Rafael López-Rojas et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by Rafael López-Rojas

Since Specialization

Citations

This map shows the geographic impact of Rafael López-Rojas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rafael López-Rojas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rafael López-Rojas more than expected).

Fields of papers citing papers by Rafael López-Rojas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rafael López-Rojas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rafael López-Rojas. The network helps show where Rafael López-Rojas may publish in the future.

Co-authorship network of co-authors of Rafael López-Rojas

This figure shows the co-authorship network connecting the top 25 collaborators of Rafael López-Rojas. A scholar is included among the top collaborators of Rafael López-Rojas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rafael López-Rojas. Rafael López-Rojas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relationship Between Different Resistance Mechanisms and Virulence in Acinetobacter baumannii 2019 ·Microbial Drug Resistance ·Paula Espinal, Alix Pantel, Dora Rolo, Sara Martí, Rafael López-Rojas, Younes Smani, Jerónimo Pachón, Jordi Vilà, Jean‐Philippe Lavigne	15
2	Comparative activity of a polyhexanide–betaine solution against biofilms produced by multidrug-resistant bacteria belonging to high-risk clones 2019 ·Journal of Hospital Infection ·Jesús Machuca, Rafael López-Rojas, Felipe Fernández-Cuenca, Álvaro Pascual	23
3	Quorum and Light Signals Modulate Acetoin/Butanediol Catabolism in Acinetobacter spp. 2019 ·Frontiers in Microbiology ·Marisel R. Tuttobene, Laura Fernández-García, Lucía Blasco, Pamela Cribb, Antón Ambroa, Gabriela Müller, Felipe Fernández-Cuenca, Inés Bleriot, Ramiro E. Rodríguez, (unknown), Rafael López-Rojas, Rocío Trastoy, María López, Germán Bou, María Tomás, María Alejandra Mussi	13
4	Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin 2016 ·PLoS ONE ·Rocío Álvarez‐Marín, Rafael López-Rojas, (unknown), María Gómez‐Ruíz, José Molina, José Miguel Cisneros, Carlos Ortíz-Leyba, Javier Aznar, José Garnacho‐Montero, Jerónimo Pachón	11
5	In vitro activity of a polyhexanide–betaine solution against high-risk clones of multidrug-resistant nosocomial pathogens 2016 ·Enfermedades Infecciosas y Microbiología Clínica ·Rafael López-Rojas, Felipe Fernández-Cuenca, (unknown), Álvaro Pascual	21
6	Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis 2016 ·International Journal of Antimicrobial Agents ·Juan Domínguez-Herrera, Rafael López-Rojas, Younes Smani, (unknown), Jerónimo Pachón	10
7	Sequence-activity relationship, and mechanism of action of mastoparan analogues against extended-drug resistant Acinetobacter baumannii 2015 ·European Journal of Medicinal Chemistry ·Xavier Vila‐Farrés, Rafael López-Rojas, María Eugenia Pachón-Ibáñez, Meritxell Teixidò, Jerónimo Pachón, Jordi Vilà, Ernest Giralt	23
8	Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli 2014 ·Journal of Antimicrobial Chemotherapy ·Jesús Machuca, A. Briales, (unknown), (unknown), Rafael López-Rojas, Fernando Docobo-Pérez, Luis Martínez‐Martínez, Jesús Rodríguez‐Baño, (unknown), Álvaro Pascual, José Manuel Rodríguez-Martínez	81
9	Emerging therapies for multidrug resistant Acinetobacter baumannii 2013 ·Trends in Microbiology ·Meritxell García‐Quintanilla, Marina R. Pulido, Rafael López-Rojas, Jerónimo Pachón, Michael J. McConnell	101
10	Impact of qnrA1, qnrB1 and qnrS1 on the efficacy of ciprofloxacin and levofloxacin in an experimental pneumonia model caused by Escherichia coli with or without the GyrA mutation Ser83Leu 2013 ·Journal of Antimicrobial Chemotherapy ·Juan Domínguez-Herrera, C. Velasco, Fernando Docobo-Pérez, José Manuel Rodríguez-Martínez, Rafael López-Rojas, A. Briales, C. Pichardo, (unknown), Jesús Rodríguez‐Baño, Álvaro Pascual, Jerónimo Pachón	27
11	Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum β-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis Model 2013 ·Antimicrobial Agents and Chemotherapy ·Fernando Docobo-Pérez, Lorena López‐Cerero, Rafael López-Rojas, Pilar Egea, Juan Domínguez-Herrera, Jesús Rodríguez‐Baño, Álvaro Pascual, Jerónimo Pachón	52
12	Treating multidrug-resistantAcinetobacter baumanniiinfection by blocking its virulence factors 2013 ·Expert Review of Anti-infective Therapy ·Rafael López-Rojas, Younes Smani, Jerónimo Pachón	13
13	Platelet-activating Factor Receptor Initiates Contact of Acinetobacter baumannii Expressing Phosphorylcholine with Host Cells 2012 ·Journal of Biological Chemistry ·Younes Smani, Fernando Docobo-Pérez, Rafael López-Rojas, Juan Domínguez-Herrera, (unknown), Jerónimo Pachón	51
14	In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii 2011 ·Clinical Microbiology and Infection ·Xavier Vila‐Farrés, Cristina García de la Mària, Rafael López-Rojas, Jerónimo Pachón, Ernest Giralt, Jordi Vilà	85
15	Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli 2011 ·International Journal of Antimicrobial Agents ·Fernando Docobo-Pérez, Patrice Nordmann, Juan Domínguez-Herrera, Rafael López-Rojas, Younes Smani, Laurent Poirel, Jerónimo Pachón	43
16	Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii 2011 ·European Journal of Clinical Microbiology & Infectious Diseases ·Rafael López-Rojas, Fernando Docobo-Pérez, María Eugenia Pachón-Ibáñez, Beatriz G. de la Torre, María Fernández‐Reyes, Catalina March, José A. Bengoechea, David Andreu, Luís Rivas, Jerónimo Pachón	25
17	In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii 2011 ·Clinical Microbiology and Infection ·Younes Smani, Rafael López-Rojas, Juan Domínguez-Herrera, Fernando Docobo-Pérez, Sara Martí, Jordi Vilà, Jerónimo Pachón	24
18	Pre-clinical studies of a new quinolone (UB-8902) against Acinetobacter baumannii resistant to ciprofloxacin 2011 ·International Journal of Antimicrobial Agents ·Rafael López-Rojas, Javier Sánchez‐Céspedes, Fernando Docobo-Pérez, Juan Domínguez-Herrera, Jordi Vilà, Jerónimo Pachón	10
19	Efficacy of tigecycline vs. imipenem in the treatment of experimental Acinetobacter baumannii murine pneumonia 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·C. Pichardo, María Eugenia Pachón-Ibáñez, Fernando Docobo-Pérez, Rafael López-Rojas, Jiménez-Mejías Me, A. García-Curiel, Jerónimo Pachón	20
20	Local imipenem activity against Pseudomonas aeruginosa decreases in vivo in the presence of siliconized latex 2010 ·European Journal of Clinical Microbiology & Infectious Diseases ·C. Pichardo, M. Carmen Conejo, Fernando Docobo-Pérez, C. Velasco, Rafael López-Rojas, Isabel Garcı́a, María Eugenia Pachón-Ibáñez, Juan M. Rodrı́guez, Jerónimo Pachón, Álvaro Pascual	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact